Falling Third-Trimester Insulin Requirements in Diabetic Pregnancies and Adverse Pregnancy Outcomes: A Systematic Review and Meta-Analysis
Authors:
Open Access
- 17 October 2025
- journal article
- review article
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (20) , 7357
Abstract
Background: There is conflicting evidence on whether falling insulin requirements (FIRs) in the third trimester are associated with adverse pregnancy outcomes. We synthesized published evidence to address this knowledge gap. Methods: We conducted a systematic review and meta-analysis, wherein we searched four bibliographic databases until September 04 2025 for articles describing third-trimester FIR and pregnancy outcomes. We assessed the risk of bias using the Quality In Prognosis Studies (QUIPS) tool, performed meta-analysis with pooled odds ratios (ORs) and 95% confidence intervals (95% CIs) for maternal and perinatal outcomes and assessed certainty of evidence (CoE) using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach. Results: We identified 2044 articles, of which nine fulfilled the eligibility criteria. Third-trimester FIR has an important association with preeclampsia [OR 3.0 (95% CI 1.41–6.38, absolute event rate (AER) 15.9%, high CoE], probably has an important association with neonatal respiratory distress [OR 2.03 (95% CI 1.27–3.26), AER 15.8%, moderate CoE]; may have an important association with a composite of outcomes reflecting placental dysfunction [OR 2.32 (95% CI 1.07–5.03), AER 13.5%, low CoE] and preterm birth [OR 2.0 (95% CI 0.51–7.85), AER 9.3%, very low CoE]; and may not have an important association with stillbirth [OR 1.5 (95% CI 0.27–8.40), AER 0.05%, low CoE], small-for-gestational-age [OR 1.29 (95% CI 0.77–2.15), AER 1.8%, low CoE], or low Apgar score at 5 minutes [OR 1.68 (95% CI 0.68–4.14), AER 2.3%, low CoE]. Conclusions: The CoE regarding associations between third-trimester FIR and adverse pregnancy outcomes varies considerably, and it remains uncertain whether these associations reflect cause or effect. Therefore, a solitary finding of third-trimester FIR does not warrant early delivery and maternal–foetal surveillance should be based on the primary clinical diagnosis.Keywords
This publication has 37 references indexed in Scilit:
- IDF Diabetes Atlas: The prevalence of pre-existing diabetes in pregnancy – A systematic review and meta-analysis of studies published during 2010–2020Diabetes Research and Clinical Practice, 2022
- Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetesDiabetologia, 2021
- MOOSE Reporting Guidelines for Meta-analyses of Observational StudiesJAMA Surgery, 2021
- The relationship of angiogenic factors to maternal and neonatal manifestations of early‐onset and late‐onset preeclampsiaPrenatal Diagnosis, 2014
- Alterations in physiology and anatomy during pregnancyBest Practice & Research Clinical Obstetrics & Gynaecology, 2013
- Long-Term Outcomes of Moderately Preterm, Late Preterm, and Early Term InfantsClinics in Perinatology, 2013
- Insulin requirements in late pregnancy in women with type 1 diabetes mellitus: A retrospective reviewDiabetes Research and Clinical Practice, 2012
- Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of directionDiabetologia, 2009
- Large decreases in insulin requirement occurred repeatedly in two pregnancies in a type 1 diabetic womanActa Diabetologica, 2006
- Effect of euglycemia on the outcome of pregnancy in insulin-dependent diabetic women as compared with normal control subjectsThe American Journal of Medicine, 1981